Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis with Neoadjuvant Chemotherapy: HARMONY Study

Momoko Tokura, Mark Malalay Ando, Yuki Kojima, Rui Kitadai,Shu Yazaki, Cyrielle Marie N. Atutubo, Rubi K. Li, Minda Z. Perez, Agnes E. Gorospe, Manuelito A. Madrid, Mel Valerie C. Ordinario, Marcelo Severino B. Imasa, Kazuki Sudo, Tatsunori Shimoi,Akihiko Suto, Shinji Kohsaka, Ryunosuke Machida,Ryo Sadachi,Masayuki Yoshida,Yasushi Yatabe, Tomomi Hata,Kenichi Nakamura,Kan Yonemori, Sho Shiino

BREAST CANCER-BASIC AND CLINICAL RESEARCH（2024）

Cited 0|Views1

No score

Key words

HER2-positive breast cancer,minimal residual disease,ctDNA,ctRNA,Todai OncoPanel,Asia

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined